Research Appraisaldiagnostic

upsML: A high-accuracy machine learning classifier for predicting Plasmodium falciparum var gene upstream groups

PloS onePangilinan, Elcid Aaron, Quenu, Mathieu, Claessens, Antoine et al.DOI

Clinical Snapshot

85CEBM
Evidence: Moderatediagnostic

PICO Framework

P — Population2,530 curated Plasmodium falciparum var gene sequences from global collection of genomes
I — InterventionupsML machine learning classifier using multiple algorithms (SVM, random forests, XGBoost, HMMER)
C — ComparatorExisting var gene classification tools and seven different machine learning methods
O — OutcomesClassification accuracy for upstream groups (upsA, upsB, upsC, upsE) and internal vs subtelomeric var genes

Bottom Line

This diagnostic accuracy study presents upsML, a machine learning classifier for P. falciparum var gene upstream group classification, achieving 83-92% accuracy across different sequence types. The tool addresses a significant gap in malaria research by enabling rapid, accurate classification of var genes, which are crucial for understanding pathogenesis and immune evasion. Trained on 2,530 curated sequences from global genomes, upsML outperforms existing tools and processes 20 genomes in under one second. While the high accuracy rates are promising, the study would benefit from more detailed validation metrics and confidence intervals. The open-source availability and practical utility make this a valuable resource for malaria researchers, particularly relevant for Australian tropical medicine programs studying P. falciparum diversity and pathogenesis in endemic regions.

Evidence: Moderate

Key Findings

  • P Value: Not reported in abstract

  • Effect Size: 83% accuracy for DBLα-tag sequences, 92% for full-length PfEMP1 sequences

  • Primary Outcome: Classification accuracy for var gene upstream groups

  • Nnt Or Sensitivity: Sensitivity and specificity metrics not provided in abstract

  • Confidence Interval: Not reported in abstract

Clinical Application

Highly feasible - open-source tool with rapid processing capability, minimal computational requirements Relevant for Northern Australian malaria research, particularly Torres Strait and Cape York regions where P. falciparum is endemic. Useful for NHMRC-funded malaria research programs and collaboration with regional partners Researchers studying P. falciparum var genes, malaria pathogenesis investigators, epidemiologists analyzing parasite diversity

Abstract

Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1), encoded by the hypervariable var gene family, is central to malaria pathogenesis, influencing both disease severity and immune evasion. Classifying var genes into upstream groups (upsA, upsB, upsC, upsE) is important for understanding parasite biology and clinical outcomes, but remains challenging, especially with partial sequences, such as the DBLα tag or RNA-Seq assemblies. We developed upsML, a machine-learning-based classifier trained on 2,530 curated var genes, to accurately assign upstream groups based on sequence features from different partial gene regions. We compared seven methods, including support vector machines, random forests, XGBoost, and HMMER models. Several models in upsML achieve accuracies of 83% for DBLα-tag sequences and 92% for full-length PfEMP1 sequences, thereby significantly outperforming existing tools. Additionally, we developed a model to distinguish internal from subtelomeric var genes, which we applied to a global collection of P. falciparum genomes, revealing a higher frequency of internal var genes in Asia. upsML is available at https://github.com/sii-scRNA-Seq/upsML, providing a robust and efficient resource for large-scale var gene analysis. It can classify var genes from 20 genomes in under one second.

References

  1. 1.Pangilinan, E. A., Quenu, M., Claessens, A., & Otto, T. D. (2026). upsML: A high-accuracy machine learning classifier for predicting Plasmodium falciparum var gene upstream groups. PLoS One. https://doi.org/10.1371/journal.pone.0344557
Share:XLinkedIn

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service